Page last updated: 2024-11-04

rofecoxib and Cholera

rofecoxib has been researched along with Cholera in 1 studies

Cholera: An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.

Research Excerpts

ExcerptRelevanceReference
" Swiss-Webster mice were dosed with celecoxib and rofecoxib and challenged with CT in ligated small intestinal loops, and intestinal segments from mice deficient in COX-1 and COX-2 were challenged with CT."1.32Role of cyclooxygenase enzymes in a murine model of experimental cholera. ( Boldogh, I; Gessell-Lee, DL; Olano, JP; Peterson, JW; Popov, VL, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gessell-Lee, DL1
Popov, VL1
Boldogh, I1
Olano, JP1
Peterson, JW1

Other Studies

1 other study available for rofecoxib and Cholera

ArticleYear
Role of cyclooxygenase enzymes in a murine model of experimental cholera.
    Infection and immunity, 2003, Volume: 71, Issue:11

    Topics: Aldehydes; Animals; Celecoxib; Cholera; Cholera Toxin; Cyclooxygenase 1; Cyclooxygenase 2; Disease M

2003